<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               7 DRUG INTERACTIONS<BR>               <BR>                  <BR>                     Tamoxifen: Coadministration of letrozole <BR>and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels of <BR>38% on average. Clinical experience in the second-line breast cancer trials <BR>indicates that the therapeutic effect of letrozole therapy is not impaired if <BR>letrozole is administered immediately after tamoxifen. <BR>                  <BR>                     Cimetidine: A pharmacokinetic interaction study with <BR>cimetidine showed no clinically significant effect on letrozole <BR>pharmacokinetics. <BR>                  <BR>                     Warfarin: An interaction study with warfarin showed <BR>no clinically significant effect of letrozole on warfarin pharmacokinetics. <BR>                  <BR>                     Other Anticancer Agents: There is no clinical <BR>experience to date on the use of letrozole in combination with other anticancer <BR>agents. <BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>